Close menu




BAYER AG NA O.N.

Photo credits: pixabay.com

Commented by Juliane Zielonka on March 15th, 2022 | 13:19 CET

BASF, Almonty Industries, Bayer - These stocks are providing the momentum

  • Tungsten

New battery technology from BASF promises faster charging times. The Ludwigshafen-based conglomerate talks of 15 minutes for charging an e-car with a 600km range. New batteries require the appropriate materials, such as the element tungsten. In this area, Almonty Industries provides supplies thanks to its resource-rich mine in South Korea. Meanwhile, Bayer AG in Leverkusen is busy shrinking itself back to health. Bayer's stock has been rising somewhat since it was announced that it was divesting its pest control division.

Read

Commented by Carsten Mainitz on March 11th, 2022 | 11:35 CET

Saturn Oil + Gas, BYD, Bayer - Winning with strong companies

  • Oil
  • Electromobility

When oil futures were trading in negative territory even for a short time at the outbreak of the Corona pandemic in the spring of 2020, many experts assumed that the black gold would remain at a low level in the long term. Only JPMorgan spoke at that time of a possible supercycle and prices over USD 100 per barrel. The analysts cited the supply shortage due to the swing towards green energy production as the reason. Due to the Ukraine crisis, supply has once again been drastically reduced, which is likely to fuel oil prices in the long term.

Read

Commented by Stefan Feulner on March 4th, 2022 | 13:33 CET

Bayer, Defence Therapeutics, Merck KGaA - At the start of the trend

  • Biotechnology

The biotech industry is the innovative engine for a pharmaceutical industry dependent on new concepts due to the shift from blockbuster products to personalized medicine. Even before Corona, more than EUR seven billion per year was invested in R&D in 2019. The development of new drugs is particularly important for the pharmaceutical industry, as patent protection for many blockbuster drugs is expiring or has already expired. For this reason, the pharmaceutical industry is now much more often entering biotech companies in the early development phases of a new drug. The example of vaccine manufacturers has successfully highlighted this strategy, which will also be applied to other diseases in the future.

Read

Commented by Stefan Feulner on March 2nd, 2022 | 11:31 CET

Bayer, Desert Gold, K+S - Market facing redistribution

  • Gold

Since Russia invaded Ukraine last week, the world has literally been turned upside down. There is bewilderment at the violence of the Russian president. Western nations are responding with sanctions against Russia, such as excluding Russian banks from the SWIFT system. In addition, the plan is to extend sanctions to other companies in various industries. Companies that are not affected benefit from this and gain market share. For example, the fertilizer industry is facing a redistribution of market conditions in favor of German suppliers.

Read

Commented by Carsten Mainitz on February 22nd, 2022 | 10:49 CET

Bayer, Memiontec, Dr. Hönle - Serious threat!

  • Investments

Water is the basis of all life. We use water for our nutrition, daily hygiene and leisure activities. Water is also a crucial economic factor as an energy source, transport medium and raw material. But access to clean drinking water is not a matter of course; even today, 1 billion people are denied it. According to various experts, this situation will soon deteriorate dramatically. By 2025, 3 billion people could be living in countries with severe water shortages. Therefore, water scarcity is an urgent issue for the future of humanity.

Read

Commented by Carsten Mainitz on February 18th, 2022 | 12:47 CET

Commerzbank, wallstreet:online, Bayer - Positive signals!

  • Investments

The US Federal Reserve is on the verge of ending its ultra-loose monetary policy and is signaling interest rate hikes soon in order to get a grip on high inflation, which is currently far above the target value of 2%. In addition, the monetary watchdogs cite future inflation risks and the robust labor market as reasons for the rising interest rates. As a result, shares of banks and financial services providers are benefiting. The successful restructuring measures, which are now generating billions in profits for the banks, also boost share prices.

Read

Commented by Juliane Zielonka on February 17th, 2022 | 12:10 CET

Peloton, Diamcor, Bayer - Trust, tangibles and expertise

  • Diamonds

Peloton gets in shape with streamlining just like its existing customers. 90% of early adopters remain loyal to the Company. Rough diamonds achieve new record prices, Diamcor profits, and so do its investors. Bayer comes up trumps in the agricultural business with innovative solutions for corn cultivation. In the upcoming market phase, investors want to be prepared. Investing in price-setters that take advantage of strong inflation makes sense. We take a look at three investment opportunities.

Read

Commented by Armin Schulz on February 7th, 2022 | 12:14 CET

Bayer, Perimeter Medical Imaging AI, Siemens Healthineers - Diagnostics as an upcoming trend in the pharmaceutical industry

  • medtech

The Corona pandemic has made many people aware of the importance of diagnostics. Without PCR and antigen tests, it would have been impossible to control the incidence of infection. But it is not only in this area that things have changed in the last 2 years. Diagnostics are becoming increasingly digitized, and so more and more tech companies are entering the market that originally had nothing to do with the pharmaceutical industry. The better the diagnostics, the earlier diseases can be detected and treated. It is a future topic in pharma. We look at three companies from this sector today.

Read

Commented by Stefan Feulner on February 2nd, 2022 | 12:45 CET

Bayer, Almonty Industries, HeidelbergCement - Delivered

  • Tungsten

To start, the good news, the inflation rate fell in January for the first time since December 2020. However, the level of 4.9% remains at a threateningly high level, and economists had expected a sharper fall. The main reasons for the inflation are the continued exorbitant rise in energy prices and rising commodities prices. High inflation is reducing consumers' purchasing power. In addition, rising production costs are squeezing companies' margins.

Read

Commented by Nico Popp on January 26th, 2022 | 11:01 CET

Bayer, MAS Gold, BASF: 5.7% dividend? These intrinsic values score now!

  • Gold

According to capital market strategist Ulrich Stephan from Deutsche Bank, substantial stocks could have an advantage in the upcoming market phase. The reason: When interest rates rise, the refinancing costs for growth companies increase significantly, as they usually do not write any or few profits. Reason enough to take a closer look at two of the best-known German substance companies and ask whether there are also growth stocks with substance.

Read